Transomic Technologies Inc.
Jason Fewell has a strong background in scientific research and development. Jason is currently serving as the Chief Scientific Officer at transOMIC technologies inc. Their previous role was as the VP Preclinical Research at Celsion Corporation from June 2014 to February 2021. Before that, they held the position of VP Preclinical Research and Development at EGEN, Inc. from July 2003 to June 2014. Jason started their career as a Senior Scientist at GeneMedicine/Valentis in April 1998 and worked there until October 2002.
Jason Fewell holds a Ph.D. in Biological Science, which they obtained from Florida State University. Prior to that, they completed their undergraduate studies at the University of North Carolina Wilmington, where they earned a Bachelor of Science degree in Marine Biology.
This person is not in any teams
Transomic Technologies Inc.
Transomic is a biotechnology startup that provides research tools to accelerate the complexity of life and human disease. It offers next-generation research tools for unraveling genetic complexity, providing bioresearch organizations with cost-effective and technically supported technologies to enable discovery across the genome. These researchtools for gene manipulation provide investigators with high-quality genes, RNAi tools, and delivery reagents for gene function analysis in relation to oncology, neuroscience, metabolic disorders.